Highlights Vanta Bioscience Limited

Equities

VANTABIO6

INE695X01011

Market Closed - Bombay S.E. Other stock markets 03:31:00 05/07/2024 pm IST			5-day change	1st Jan Change
56.6 ^INR	+3.66%		+8.85%	+5.70%

03/04	Vanta Bioscience Bags INR12 Million Order to Conduct Technical Studies	MT
02/04	Vanta Bioscience Limited Receives an Order of INR 12 Million from A Large Indian Multinational Company	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vanta Bioscience Bags INR12 Million Order to Conduct Technical Studies	03/04	MT
Vanta Bioscience Limited Receives an Order of INR 12 Million from A Large Indian Multinational Company	02/04	CI
Vanta Bioscience Bags INR5.7 Million Order for Good Laboratory Practices Studies	04/12	MT
Vanta Bioscience Limited Receives Order of INR 5.7 Million from Singapore Company to Carry Out GLP Studies	01/12	CI
Vanta Bioscience Limited Reports Earnings Results for the Half Year Ended September 30, 2023	14/11	CI
Vanta Bioscience Limited Reports Earnings Results for the Full Year Ended March 31, 2023	10/23/10	CI
Vanta Bioscience Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/22/30	CI
Vanta Bioscience to Conduct Animal and Agrochem Studies for Coromandel International	04/22/04	MT
Vanta Bioscience Limited Receives Order of INR 11.8 Million from Coromandel International Limited	04/22/04	CI
Vanta Bioscience Limited Reports Earnings Results for the Half Year Ended September 30, 2021	11/21/11	CI
Vanta Bioscience : Receives Full Accreditation from AAALAC Council	14/21/14	MT
Vanta Bioscience : Gains Indian Accreditation to Board's Recommendation to Continue Biological Testing	14/21/14	MT
Vanta Bioscience Limited Reports Earnings Results for the Full Year Ended March 31, 2021	28/21/28	CI
Vanta Bioscience Limited Enters into Commercial Agreement with One of the Leading German Testing Agency	13/20/13	CI
Vanta Bioscience Limited Reports Earnings Results for the Half Year Ended September 30, 2020	13/20/13	CI
Vanta Bioscience Limited Reports Earnings Results for the Full Year Ended March 31, 2020	30/20/30	CI
Vanta Bioscience Limited Reports Earnings Results for the Half Year Ended September 30, 2019	13/19/13	CI
Vanta Bioscience Limited Reports Standalone and Consolidated Audited Earnings Results for the Half Year and Full Year Ended March 31, 2019	22/19/22	CI
Vanta Bioscience Limited Reports Unaudited Earnings Results for the Half Year Ended September 30, 2018	09/18/09	CI
Vanta Bioscience Limited Incorporates Wholly Owned Subsidiary Vanta Clinical Research Limited	09/18/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Vanta Bioscience Limited

Equities

VANTABIO6

INE695X01011

Highlights

Filters